225 related articles for article (PubMed ID: 22397586)
1. Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors.
Seitz PK; Bremer NM; McGinnis AG; Cunningham KA; Watson CS
BMC Neurosci; 2012 Mar; 13():25. PubMed ID: 22397586
[TBL] [Abstract][Full Text] [Related]
2. Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction.
Felsing DE; Anastasio NC; Miszkiel JM; Gilbertson SR; Allen JA; Cunningham KA
PLoS One; 2018; 13(8):e0203137. PubMed ID: 30157263
[TBL] [Abstract][Full Text] [Related]
3. Endogenous 5-HT2C Receptors Phosphorylate the cAMP Response Element Binding Protein via Protein Kinase C-Promoted Activation of Extracellular-Regulated Kinases-1/2 in Hypothalamic mHypoA-2/10 Cells.
Lauffer L; Glas E; Gudermann T; Breit A
J Pharmacol Exp Ther; 2016 Jul; 358(1):39-49. PubMed ID: 27189964
[TBL] [Abstract][Full Text] [Related]
4. Coevolution of Residues Provides Evidence of a Functional Heterodimer of 5-HT
Fongang B; Cunningham KA; Rowicka M; Kudlicki A
Neuroscience; 2019 Aug; 412():48-59. PubMed ID: 31158438
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
[TBL] [Abstract][Full Text] [Related]
6. Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2.
Werry TD; Gregory KJ; Sexton PM; Christopoulos A
J Neurochem; 2005 Jun; 93(6):1603-15. PubMed ID: 15935077
[TBL] [Abstract][Full Text] [Related]
7. Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity.
Anastasio NC; Stutz SJ; Fink LH; Swinford-Jackson SE; Sears RM; DiLeone RJ; Rice KC; Moeller FG; Cunningham KA
ACS Chem Neurosci; 2015 Jul; 6(7):1248-58. PubMed ID: 26120876
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
Knauer CS; Campbell JE; Chio CL; Fitzgerald LW
Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):461-71. PubMed ID: 19057895
[TBL] [Abstract][Full Text] [Related]
9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Serotonin 5-HT
Price AE; Sholler DJ; Stutz SJ; Anastasio NC; Cunningham KA
ACS Chem Neurosci; 2019 Jul; 10(7):3241-3248. PubMed ID: 30645940
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT
Chen J; Garcia EJ; Merritt CR; Zamora JC; Bolinger AA; Pazdrak K; Stafford SJ; Mifflin RC; Wold EA; Wild CT; Chen H; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2023 Jul; 66(14):9992-10009. PubMed ID: 37462530
[TBL] [Abstract][Full Text] [Related]
12. The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B.
Scarlota LC; Harvey JA; Aloyo VJ
Psychopharmacology (Berl); 2011 Feb; 213(2-3):393-401. PubMed ID: 20652541
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)
Kozell LB; Eshleman AJ; Swanson TL; Bloom SH; Wolfrum KM; Schmachtenberg JL; Olson RJ; Janowsky A; Abbas AI
J Pharmacol Exp Ther; 2023 Apr; 385(1):62-75. PubMed ID: 36669875
[TBL] [Abstract][Full Text] [Related]
15. Novel Bivalent 5-HT
Soto CA; Shashack MJ; Fox RG; Bubar MJ; Rice KC; Watson CS; Cunningham KA; Gilbertson SR; Anastasio NC
ACS Chem Neurosci; 2018 Mar; 9(3):514-521. PubMed ID: 29111677
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.
Dougherty JP; Aloyo VJ
Psychopharmacology (Berl); 2011 Jun; 215(3):581-93. PubMed ID: 21340474
[TBL] [Abstract][Full Text] [Related]
17. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
Berg KA; Stout BD; Maayani S; Clarke WP
J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT
Land MA; Chapman HL; Davis-Reyes BD; Felsing DE; Allen JA; Moeller FG; Elferink LA; Cunningham KA; Anastasio NC
Sci Rep; 2019 Nov; 9(1):16737. PubMed ID: 31723224
[TBL] [Abstract][Full Text] [Related]
19. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.
Zhang X; Andren PE; Svenningsson P
Physiol Behav; 2007 Sep; 92(1-2):29-33. PubMed ID: 17588622
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT
Wild CT; Miszkiel JM; Wold EA; Soto CA; Ding C; Hartley RM; White MA; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2019 Jan; 62(1):288-305. PubMed ID: 29620897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
